Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mavacamten in Obstructive Hypertrophic Cardiomyopathy
CTR20212890Phase 3Completed
- Sponsor
- Lian Cardiovascular
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mavacamten in hypertrophic cardiomyopathy (HCM), sponsored by Lian Cardiovascular. Started Nov 2021; status: completed.
02
Drugs
mavacamten
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on CTR20212890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212890.